Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization. (Q47898529)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

title

Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

author name string

H Guo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

Q Zhu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

X Yu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

S B Merugu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

N Smith

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

Z Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

B Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

H Negi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

R Rong

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

K Cheng

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

Z Wu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

D Li

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

English

0 references

publication date

8 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

issue

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

5098-5109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

Targeting the tumor microenvironment for cancer therapy

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

The tumor microenvironment at a glance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Targeting the tumor microenvironment: from understanding pathways to effective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Target molecules for anti-angiogenic therapy: from basic research to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Novel targets for VEGF-independent anti-angiogenic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Antiangiogenic therapies: going beyond their limits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Anterior gradient 2: A novel player in tumor cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Mechanisms of anterior gradient-2 regulation and function in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Agr2 mediates paracrine effects on stromal fibroblasts that promote invasion by gastric signet-ring carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

VEGF and the quest for tumour angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Antiangiogenic Therapies in Epithelial Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Targeting angiogenesis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Physiological stress induces the metastasis marker AGR2 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Angiogenesis: a promising therapeutic target for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Structural basis for FGF receptor dimerization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Development of a fluorescent monoclonal antibody-based assay to measure the allosteric effects of synthetic peptides on self-oligomerization of AGR2 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

The fibroblast growth factor-binding protein FGF-BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Role of vascular endothelial growth factor in the regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Antiangiogenic and anticancer effect of an orally active low molecular weight heparin conjugates and its application to lung cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

An agarose spot assay for chemotactic invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

RhoA and Rac1 play independent roles in lysophosphatidic acid-induced ovarian cancer chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Isolation of interstitial fluid from rat mammary tumors by a centrifugation method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Body fluid proteomics: Prospects for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Therapeutic targeting of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2017.132

Isolation of mouse peritoneal cavity cells

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28481872

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Preparation, characterization and potential application of monoclonal antibody 18A4 against AGR2]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28481872

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2017.132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28481872 AND SRC:MED&resulttype=core&format=json

19 March 2020

1 reference